Mirae Asset Global Investments Co., Ltd. Amarin Corp Plcuk Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 14,472 shares of AMRN stock, worth $6,367. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,472
Previous 11,935
21.26%
Holding current value
$6,367
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding AMRN
# of Institutions
177Shares Held
65.1MCall Options Held
258KPut Options Held
98K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$10.9 Million3.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$5.46 Million0.64% of portfolio
-
Eversept Partners, LP New York, NY3.31MShares$1.46 Million0.16% of portfolio
-
Morgan Stanley New York, NY2.55MShares$1.12 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.1 Million1.16% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $177M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...